- Bone marrow involvement by primary oxalosis
-
Fratoni S, Niscola P
- KMID: 2509956
- Blood Res.
- 2020 Dec;55(4):192-192.
- doi: 10.5045/br.2020.2020156
-
- CITED
-
- Close
- SHARE
-
- Close
- Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome
-
Niscola P, Tendas A, Scaramucci L, Giovannini M, Fratoni S, de Fabritiis P
- KMID: 2172917
- Blood Res.
- 2013 Jun;48(2):152-153.
- doi: 10.5045/br.2013.48.2.152
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent
-
Niscola P, Tendas A, Scaramucci L, Giovannini M, Fratoni S, de Fabritiis P
- KMID: 2172776
- Blood Res.
- 2015 Jun;50(2):113-114.
- doi: 10.5045/br.2015.50.2.113
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis
-
Niscola P, Catalano G, Fratoni S, Scaramucci L, de Fabritiis P, Caravita T
- KMID: 2270712
- Blood Res.
- 2013 Sep;48(3):228-230.
- doi: 10.5045/br.2013.48.3.228
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
-
Niscola P, Palombi M, Fratoni S, Perrotti A, de Fabritiis P
- KMID: 2172880
- Blood Res.
- 2013 Dec;48(4):296-297.
- doi: 10.5045/br.2013.48.4.296
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin
-
Niscola P, Palombi M, Fratoni S, Trawinska , Scaramucci L, Tendas A, Giovannini M, Perrotti A, de Fabritiis P
- KMID: 1832113
- Korean J Hematol.
- 2012 Dec;47(4):309-310.
- doi: 10.5045/kjh.2012.47.4.309
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
